立克次氏体2点IgM免疫荧光玻片试剂盒

Rickettsia 2-Antigen MIF IgM kit

广州健仑生物科技有限公司

主要用途：用于检测人血清中的立克次氏体 2 点 IgM 抗体

产品规格：12 孔/张,10 张/盒

主要产品包括：包柔氏螺旋体菌、布鲁氏菌、贝纳特氏立克次体、土伦杆菌、钩端螺旋体、新型立克次体、恙虫病、立克次体、果氏巴贝西虫、马焦虫、牛焦虫、利什曼虫、新包虫、弓形虫、猫流感病毒、猫冠状病毒、猫疱疹病毒、犬瘟病毒、犬细小病毒等病原微生物的 IFA、MIF、ELISA试剂。

立克次氏体2点IgM免疫荧光玻片试剂盒

我司还提供其它进口或国产试剂盒：登革热、疟疾、西尼罗河、立克次体、无形体、蜱虫、恙虫、利什曼原虫、RK39、汉坦病毒、深林脑炎、流感、A链球菌、合胞病毒、腮病毒、乙脑、寨卡、黄热病、基孔肯雅热、克锥虫病、违禁品滥用、肺炎球菌、军团菌、化妆品检测、食品安全检测等试剂盒以及日本生研细菌分型诊断血清、德国SiFin诊断血清、丹麦SSI诊断血清等产品。

欢迎咨询

欢迎咨询2042552662

二维码扫一扫

【公司名称】 广州健仑生物科技有限公司
【】    杨永汉 
【】 
【腾讯 】 2042552662
【公司地址】 广州清华科技园创新基地番禺石楼镇创启路63号二期2幢101-3室
【企业文化】

预后良好的患者可幸免进行带有严重副作用的侵入性治疗，但不对侵入性肿瘤进行侵入治疗或可导致死亡。癌症之所以致命，在很大程度上是由于其发生了转移，从一个器官或组织转移到另一个器官或组织。癌症致死绝大多数与转移有关。
对于抗原抗体癌来说，被称为“上皮间质转化”的过程助推了这种转移。上皮细胞系附着在与环境接触的皮肤和胃肠道中。间质细胞是胚胎组织和结缔组织中的一种细胞类型，其在那里形成非常松散的。肿瘤细胞失去成熟上皮细胞的特性(如附着于环境的能力)，获得间质细胞的能力，使其能够轻松地在细胞间流动并进入血液，从而迁移到远处的器官和组织。
加拿大麦吉尔大学乔西·尤西尼-西格尔主持的新研究表明，p66ShcA蛋白富含于经历了上皮间质细胞转移的抗原抗体癌中。在所有抗原抗体癌类型中，p66ShcA表达水平的升高与上皮间质细胞转化基因的表达密切相关。因此，p66ShcA可用作确定各种分子亚型抗原抗体癌预后的*标记。
抗原抗体癌至少有5种亚型，其中每一种都与不同预后结果相关。早期研究表明，亚型具有异质性，因此基于亚型的预后结果不太可靠。研究人员表示，对造成肿瘤细胞异质性和转移基本机制的深入了解，有助于更好地明确疾病的预后发展并提出改善治疗效果的方法。

Patients with good prognosis can be spared aggressive treatment with serious side effects, but not invasive treatment of invasive tumors or can lead to death. The cancer is fatal, in large part because of its metastasis, its transfer from one organ or tissue to another organ or tissue. The vast majority of cancer death and metastasis.
For antigen-antibody cancers, a process called "epithelial mesenchymal transition" helps to promote this metastasis. Epithelial cell lines attach to the environment in contact with the skin and gastrointestinal tract. Stromal cells are a type of cell in embryonic tissue and connective tissue where they form a very loose connection. Tumor cells lose the properties of mature epithelial cells (such as their ability to attach to the environment) and gain the ability of interstitial cells to migrate easily to and from the bloodstream to distant organs and tissues.
New research led by Josie Ussini-Siegel of McGill University in Canada shows that the p66ShcA protein is enriched in antigen-antibody cancers that have undergone epithelial mesenchymal cell metastasis. In all antigen-antibody cancer types, the increased expression of p66ShcA is closely related to the expression of epithelial-derived stromal cells. Therefore, p66ShcA can be used as a first choice marker for determining the prognosis of various molecular subtype antigens.
Antigen Antibody The cancer has at least 5 subtypes, each of which is associated with a different outcome. Early studies have shown that subtypes are heterogeneous, so prognosis based on subtypes is less reliable. The researchers said that an in-depth understanding of the underlying mechanisms responsible for tumor cell heterogeneity and metastasis can help to better define the prognosis of the disease and suggest ways to improve the outcome.